Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

ACRS Aclaris Therapeutics

15.750
-0.270-1.69%
Close 10/05 16:00 ET
15.760
+0.010+0.06%
Pre Mkt Price 10/06 05:16 ET
High
15.940
Open
15.790
Turnover
4.25M
Low
15.573
Pre Close
16.020
Volume
269.87K
Market Cap
1.05B
P/E(TTM)
Loss
52wk High
18.622
Shares
66.67M
P/E(Static)
Loss
52wk Low
9.260
Float Cap
688.68M
Bid/Ask %
0.00%
Historical High
33.880
Shs Float
43.73M
Volume Ratio
0.87
Historical Low
0.700
Dividend TTM
--
Div Yield TTM
--
P/B
4.45
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.62%
Amplitude
2.29%
Avg Price
15.734
Lot Size
1
Float Cap
688.68M
Bid/Ask %
0.00%
Historical High
33.880
Shs Float
43.73M
Volume Ratio
0.87
Historical Low
0.700
Dividend TTM
--
P/B
4.45
Dividend LFY
--
Turnover Ratio
0.62%
Amplitude
2.29%
Avg Price
15.734
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through the Therapeutics and Contract Research segments. The Therapeutics segment focuses on identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.
CEO: Dr. Neal Walker
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...